CORONA REMEDIES LIMITED (CORONA)

NSE: ₹1,701.30
BSE: ₹1,701.95
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 361.13 342.42 353.09
YOY Revenue Growth % - - -
Other Income 2.27 2.24 4.11
Total Income 363.40 344.66 357.20
Total Expenses + 293.79 270.37 302.74
Cost of Materials Consumed 25.90 24.82 27.73
Employee Benefit Expense 103.00 95.94 106.63
Other Expenses 111.01 103.05 118.20
Operating Profit 67.34 72.05 50.35
OPM % 18.6% 21% 14.3%
Profit Before Tax + 69.61 55.19 54.46
Tax Expense 17.46 13.94 9.41
Tax % 25.1% 25.3% 17.3%
Profit After Tax 52.15 41.25 45.05
EPS (Basic) 8.53 6.74 7.37

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 1,403.18
YOY Revenue Growth % -
Other Income 10.65
Total Income 1,413.83
Total Expenses + 1,154.58
Cost of Materials Consumed 103.51
Employee Benefit Expense 403.02
Other Expenses 445.78
Operating Profit 248.60
OPM % 17.7%
Profit Before Exceptional 259.25
Exceptional Items -19.10
Profit Before Tax + 240.15
Tax Expense 55.30
Tax % 23%
Profit After Tax 184.85
EPS (Basic) 30.22

Balance Sheet

Particulars Mar 2026
ASSETS
Non-Current Assets + 855.94
Property, Plant & Equipment 291.14
Capital Work in Progress 143.12
Non-Current Investments 25.40
Goodwill 0.00
Other Intangible Assets 262.83
Current Assets + 348.31
Inventories 125.00
Trade Receivables 145.55
Cash and Cash Equivalents 1.83
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 745.97
Equity Share Capital 61.16
Other Equity 684.81
Non-Current Liabilities 97.11
Current Liabilities 361.17
Total Liabilities 458.28

Cash Flow Statement

Particulars Mar 2026
Cash from Operating Activities 229.48
Cash from Investing Activities -256.15
Cash from Financing Activities 25.28
Net Increase/Decrease in Cash -1.39